Wednesday, February 10, 2010, 2:23PM AEST - The Australian Stockmarket closes in 1 hour and 42 minutes.
To create a watchlist or portfolio of shares, Register

DepoMed Inc. (DEPO)

8:00AM AEST: 2.90 USD  Up 0.10 (3.57%)  
 MORE ON DEPO 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Depomed, Inc. (NGM:DEPO) Delayed quote dataEdit
Last Trade:2.90 USD
Trade Time: 8:00AM AEST
Change:Up 0.10 (3.57%)
Prev Close:2.80
Open:2.86
Bid:2.80 x 100
Ask:3.20 x 100
1y Target Est:7.83
Day's Range:2.84 - 2.93
52wk Range:1.66 - 6.40
Volume:235,356
Avg Vol (3m):284,597
Market Cap:150.83M
P/E (ttm):N/A
EPS (ttm):-0.58
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add DEPO to Portfolio   Download Data

 HEADLINES 
Depomed to Present at the 12th Annual BIO CEO & Investor Conference
Business Wire (Wed, Feb 3)
Depomed Announces Allowance of U.S. Patent Covering Gastric Retentive Gabapentin Dosage Forms
Business Wire (Tue, Feb 2)
Depomed Announces Receipt of $500,000 Milestone Payment from Covidien for the Development of a Second Formulation
Business Wire (Fri, Jan 22)
DEPOMED INC Files SEC form 8-K, Other Events
EDGAR Online (Thu, Jan 21)
UPDATE - Depomed to conduct another trial for hot flashes drug
at Reuters (Wed, Jan 20)
Depomed Comments on FDA Guidance and Plans for One Additional Phase 3 Clinical Trial Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes
Business Wire (Wed, Jan 20)
5 Cold Stocks Heating Up
at Motley Fool (Sat, Jan 16)
DEPOMED INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Sat, Jan 9)
Neutral on Santarus
Zacks.com (Thu, Jan 7)
Zacks #5 Rank Additions for Wednesday
Zacks.com (Wed, Jan 6)
Huge Leaps for Small-Cap Pharma Plays
Indie Research (Wed, Dec 16)
Prospecting for Stocks: DepoMed
at Motley Fool (Wed, Dec 9)
More Headlines for DEPO...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.49
EPS Est (in 2 years) (Dec-10) :-0.49
Avg Rec (current)*:1.8
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices